LifeMD Inc reports results for the quarter ended in March - Earnings Summary

LifeMD

09/05/2024 16:21

* LifeMD Inc  LFMD.OQ  reported a quarterly adjusted loss
of 19
cents​​ per share for the quarter ended in March, lower than the
same quarter last year, when the company reported EPS of -15
cents.  The mean expectation of five analysts for the quarter
was for a loss of 15 cents per share. Wall Street expected
results to range from -18 cents to -9 cents per share.
    * Revenue rose 33.3% to $44.14 million from a year ago;
analysts
expected $42.54 million. 
    * LifeMD Inc's reported EPS for the quarter was a loss of 19
cents​.
    * The company reported a quarterly loss of $7.54 million.
    * LifeMD Inc shares had risen by 19.9% this quarter and
gained 48.7% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 16.7%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "buy"

Wall Street's median 12-month price target for LifeMD Inc is
$12.00 
This summary was machine generated from LSEG data May 9 at 03:20
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.15          -0.19          Missed
 Dec. 31 2023      -0.14          -0.12          Beat
 Sep. 30 2023      -0.15          -0.20          Missed
 Jun. 30 2023      -0.10          -0.23          Missed